Prenetics Global (NASDAQ: PRE) recently disclosed record financial results for the fourth quarter and full year of fiscal 2025.
Show original
Its core business line, IM8, achieved an annualized revenue (ARR) of $120 million within just 12 months, demonstrating strong growth momentum. Even more remarkable, the company’s overall revenue increased by 480% year-on-year, reflecting the tremendous potential of its business model and effective market expansion strategies. This outstanding performance is attributed to the company’s continuous innovation and strategic execution in the field of precision medicine, marking a key step for Prenetics in advancing global health solutions.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Overview of Key Overnight Developments on March 8
金色财经•2026/03/07 23:36
Iran says fuel supply in Tehran Province and Alborz Province remains stable
华尔街见闻•2026/03/07 21:47
Data: BTC falls below $67,000
Chaincatcher•2026/03/07 19:52
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$67,474.39
-1.00%
Ethereum
ETH
$1,976.61
-0.14%
Tether USDt
USDT
$0.9999
+0.01%
BNB
BNB
$621.52
-1.04%
XRP
XRP
$1.36
-0.57%
USDC
USDC
$1
+0.01%
Solana
SOL
$83.36
-1.75%
TRON
TRX
$0.2868
+0.72%
Dogecoin
DOGE
$0.09006
-1.41%
Cardano
ADA
$0.2546
-1.80%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now